Company news: Haymarket Medical, Johnson & Johnson

Share this article:
Company news: Haymarket Medical, Johnson & Johnson
Company news: Haymarket Medical, Johnson & Johnson

Hitting the 1,000-download mark in less than a week, Haymarket Medical said its new myCME app has been an iTunes top 10 US medical app ever since. The May 10 launch was a universal app for iPhone/iPad and iPod users. An Android version will be released later this month. MM&M is a Haymarket title. 


Advanced prostate cancer drug Zytiga could help men who are in the earlier stages of the disease, reported the New York Times. The report was based on small, six-month clinical trial in which the Johnson & Johnson drug was added to standard therapy. The Times reported that the combination cleared or nearly eliminated tumors in about a third of the men whose cancer was still limited to the prostate gland. Full results will be reported at the American Society of Oncology's June conference in Chicago.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA lifts OncoMed partial hold

The FDA froze the clinical trial of anti-Fzd7 vantictumab in July over concern about "bone-related adverse events."

Research links estrogen and binge eating

Baylor College of Medicine researchers have found that an estrogen replacement suppressed binge-eating behavior among lab mice.

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.